UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of April, 2015
Commission File Number 1-14840
AMDOCS LIMITED
Hirzel House, Smith Street,
St. Peter Port, Island of Guernsey, GY1 2NG
Amdocs, Inc.
1390 Timberlake Manor Parkway, Chesterfield, Missouri 63017
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
FORM 20-F x FORM 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:
YES ¨ NO x
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-
On April 29, 2015, Amdocs Limited (“Amdocs”) issued a press release announcing financial results for the quarter ended March 31, 2015, and its entry into a definitive agreement to acquire a substantial majority of the assets of the business support systems business unit of Comverse, Inc. for approximately $272 million, subject to customary closing conditions. A copy of the press release is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K.
The information in this Form 6-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| AMDOCS LIMITED | ||
| By: | /s/ Matthew E. Smith | |
| Matthew E. Smith | ||
| Secretary and Authorized Signatory | ||
Date: April 29, 2015
EXHIBIT INDEX
| EXHIBIT |
DESCRIPTION | |
| 99.1 | Amdocs Limited Press Release dated April 29, 2015. | |
Exhibit 99.1
Amdocs Limited Reports Quarterly Revenue of $903M, In Line With
Midpoint of Guidance on a Constant Currency Basis;
Reiterates FY15 Non-GAAP Diluted EPS Growth Outlook of 4.5%-7.5% YoY
Key highlights:
| • | Signed definitive agreement on April 29, 2015, to acquire a substantial majority of Comverse’s business support systems (BSS) business unit assets for approximately $272 million in cash, subject to customary closing conditions. The Boards of Directors of Comverse and Amdocs have approved the transaction which, subject to the satisfaction of the conditions to closing, is expected to be completed before the end of September 2015 |
| • | Second fiscal quarter revenue of $903 million, within the $900-$930 million guidance range. Excluding foreign currency movements, revenue was in line with the midpoint of our expectations. Foreign currency movements negatively affected revenue by approximately $16 million relative to the first quarter of fiscal 2015 |
| • | Second fiscal quarter non-GAAP operating income of $153 million; non-GAAP operating margin of 17.0%; GAAP operating income of $138 million |
| • | Second fiscal quarter diluted non-GAAP EPS of $0.82, within the $0.78-$0.84 guidance range, excluding amortization of purchased intangible assets and other acquisition-related costs, changes in fair value of certain acquisition-related liabilities and equity-based compensation expense, net of related tax effects |
| • | Diluted GAAP EPS of $0.74 for the second fiscal quarter, above the $0.64-$0.72 guidance range |
| • | Free cash flow of $115 million for the second fiscal quarter |
| • | Repurchased $111 million of ordinary shares during the second fiscal quarter |
| • | Twelve-month backlog of $3.0 billion at the end of the second fiscal quarter, down $30 million from the end of the first quarter of fiscal 2015. Excluding foreign currency movements, twelve-month backlog was up $30 million from the end of the first quarter of fiscal 2015 |
| • | The Board of Directors approved a $0.17 per share quarterly cash dividend to be paid on July 17, 2015 |
| • | Third quarter fiscal 2015 guidance: Expected revenue of approximately $885-$925 million. Expected diluted non-GAAP EPS of approximately $0.79-$0.85, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.05-$0.06 per share of equity-based compensation expense, net of related tax effects. Expected diluted GAAP EPS of approximately $0.65-$0.73. Third quarter fiscal 2015 guidance does not incorporate any contribution from the acquisition of the Comverse BSS assets |
| • | Full year fiscal 2015 revenue guidance: Reiterates fiscal 2015 revenue growth within the range of 2.5% to 5.5% year-over-year on a constant currency basis relative to the guidance provided on November 4, 2014. Expects fiscal 2015 reported revenue growth of 0.3% to 3.3% year-over-year reflecting a negative impact from foreign currency movements of over 2% relative to the guidance provided on November 4, 2014. Full year fiscal 2015 guidance does not incorporate any contribution from the acquisition of the Comverse BSS assets |
| • | The impact of the acquisition of the Comverse BSS assets on Amdocs’ diluted non-GAAP earnings per share (excluding amortization of purchased intangible assets and other acquisition related costs and equity-based compensation expense, net of related tax effects) is expected to be neutral in the first year after closing, and accretive thereafter. The impact on diluted GAAP EPS will not be known until after Amdocs completes the purchase price allocation. Amdocs expects to incur acquisition-related expenses related to operating adjustments, restructuring charges and other acquisition-related costs |
ST. LOUIS – April 29, 2015 – Amdocs Limited (NASDAQ: DOX) today reported that for its fiscal quarter ended March 31, 2015, revenue was $902.6 million, down 0.4% sequentially from the first fiscal quarter of 2015 and up 0.6% as compared to last year’s second fiscal quarter. Second fiscal quarter revenue includes a negative impact from foreign currency movements of approximately $16 million relative to the first quarter of fiscal 2015. Net income on a non-GAAP basis was $128.6 million, or $0.82 per diluted share, compared to non-GAAP net income of $131.9 million, or $0.81 per diluted share, in the second quarter of fiscal 2014. Non-GAAP net income excludes amortization of purchased intangible assets and other
acquisition-related costs, changes in fair value of certain acquisition-related liabilities and equity-based compensation expenses of $12.4 million, net of related tax effects, in the second quarter of fiscal 2015 and excludes such amortization and other acquisition-related costs and equity-based compensation expenses of $21.5 million, net of related tax effects, in the second quarter of fiscal 2014. The Company’s GAAP net income for the second quarter of fiscal 2015 was $116.3 million, or $0.74 per diluted share, compared to GAAP net income of $110.4 million, or $0.68 per diluted share, in the prior fiscal year’s second quarter.
“We are pleased with our second fiscal quarter results, which included revenue in line with the mid-point of our expectations after adjusting for the negative impact of foreign currencies. We remained focused on delivering value to our customers, including in North America where market dynamics continue to change rapidly. In Europe, we strengthened relationships with some of our long-standing customers. EE, the UK’s largest mobile operator, has extended its managed services contract with Amdocs to develop and maintain its BSS platform. We also expanded our business within additional buying centers of existing customers. These include TeliaSonera where our mobile network optimization solutions have been selected to improve customer experience and network performance across Sweden, Norway, Finland, Estonia and Lithuania,” said Eli Gelman, president and chief executive officer of Amdocs Management Limited.
Gelman continued, “Our Rest-of-World markets delivered record revenue in the second quarter as we made progress on a number of highly complex transformation projects. Amdocs has just completed the deployment of an integrated Amdocs BSS platform to provide billing business services for Vodafone India’s enterprise customers. This is part of a larger BSS transformation program in which Vodafone India is also migrating all postpaid customers onto a consolidated Amdocs billing platform. At the same time, our sales momentum continued at new customers in these regions and included a BSS project award at Kcell, an affiliate of TeliaSonera and Kazakhstan’s largest mobile operator.”
Gelman said, “The strategic use of M&A remains an important vehicle for executing on our long-term objectives. Along these lines, today we signed a definitive agreement to acquire a substantial majority of the business support system assets of Comverse for approximately $272 million in cash. The acquisition geographically complements Amdocs’ market focus by expanding and diversifying Amdocs’ global customer base, particularly in Asia Pacific, Latin
America and Europe, and including Europe’s cable and satellite market. As we move forward, the strength of our company and unique business model will enable Amdocs to bring additional value, innovation and a broader range of offerings as we leverage our joint professional industry expertise for the benefit of our customers.”
Gelman concluded, “We returned more than 100% of free cash flow to shareholders in the second fiscal quarter, and with the stability of our business model and consistent operating execution, we remain committed to our balanced capital allocation framework over the long-term. Taking all factors into consideration, we are on-track to deliver diluted non-GAAP earnings per share growth of 4.5%-7.5% for the full fiscal year 2015, and, with our dividend yield, maximize the total return we expect to provide to shareholders.”
Financial Discussion of Second Fiscal Quarter Results
Free cash flow was $115 million for the quarter, comprised of cash flow from operations of $135 million less $20 million in net capital expenditures and other.
Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was $3.0 billion at the end of the second quarter of fiscal 2015, down $30 million sequentially as reported but up $30 million sequentially on a constant currency basis.
Financial Outlook
Amdocs expects that revenue for the third quarter of fiscal 2015 will be approximately $885-$925 million. This outlook takes into consideration our expectations regarding macro and industry specific risks and various uncertainties resulting from current and potential customer consolidation activity in North America. However, we remind you that we cannot predict all possible outcomes.
Diluted earnings per share on a non-GAAP basis for the third fiscal quarter are expected to be $0.79-$0.85, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.05-$0.06 per share of equity-based compensation expense, net of related tax effects. Amdocs estimates GAAP diluted earnings per share for the third fiscal quarter will be $0.65-$0.73.
Quarterly Cash Dividend Program
On April 29, 2015, the Board approved the Company’s next quarterly cash dividend payment of $0.17 per share and set June 30, 2015 as the record date for determining the shareholders entitled to receive the dividend, which is payable on July 17, 2015.
Conference Call Details
Amdocs will host a conference call on April 29, 2015 at 5:00 p.m. Eastern Time to discuss the Company’s second fiscal quarter results. To participate, please dial +1 (888) 771-4371, or +1 (847) 585-4405 outside the United States, approximately 15 minutes before the call and enter passcode 39084990. The call will also be carried live on the Internet via the Amdocs website, www.amdocs.com.
Non-GAAP Financial Measures
This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expense, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth. These non-GAAP measures exclude the following items:
| • | amortization of purchased intangible assets and other acquisition-related costs; |
| • | changes in fair value of certain acquisition-related liabilities |
| • | equity-based compensation expense; and |
| • | tax effects related to the above. |
These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs’ results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs’ results of operations in conjunction with the corresponding GAAP measures.
Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expense, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.
For its internal budgeting process and in monitoring the results of the business, Amdocs’ management uses financial statements that do not include amortization of purchased intangible assets and other acquisition-related costs, changes in fair value of certain acquisition-related liabilities, equity-based compensation expense and related tax effects. Amdocs’ management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.
Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of revenue, research and development, selling, general and administrative, operating income, interest and other expense, net, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.
About Amdocs
For more than 30 years, Amdocs has ensured service providers’ success and embraced their biggest challenges. To win in the connected world, service providers rely on Amdocs to simplify the customer experience, harness the data explosion, stay ahead with new services and improve operational efficiency. The global company uniquely combines a market-leading BSS, OSS and network control and optimization product portfolio with value-driven professional services and managed services operations. With revenue of $3.6 billion in fiscal 2014, Amdocs and its over 22,000 employees serve customers in more than 80 countries.
Amdocs: Embrace Challenge, Experience Success.
For more information, visit Amdocs at www.amdocs.com.
This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs’ growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs’ ability to grow in the business markets that it serves, Amdocs’ and Comverse’s abilities to close Amdocs’ proposed acquisition of Comverse assets, Amdocs’ ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company’s products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, the Company specifically disclaims any obligation to do so. These and other risks are discussed at greater length in the Company’s filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2014 filed on December 8, 2014 and our Form 6-K furnished for the first quarter of fiscal 2015 on February 9, 2015.
Contact:
Matthew Smith
Head of Investor Relations
Amdocs
314-212-8328
E-mail: dox_info@amdocs.com
AMDOCS LIMITED
Consolidated Statements of Income
(in thousands, except per share data)
| Three months ended | Six months ended | |||||||||||||||
| March 31, | March 31, | |||||||||||||||
| 2015 | 2014 | 2015 | 2014 | |||||||||||||
| Revenue |
$ | 902,578 | $ | 896,854 | $ | 1,808,865 | $ | 1,760,899 | ||||||||
| Operating expenses: |
||||||||||||||||
| Cost of revenue |
580,571 | 583,284 | 1,154,017 | 1,140,687 | ||||||||||||
| Research and development |
62,805 | 63,104 | 126,446 | 125,429 | ||||||||||||
| Selling, general and administrative |
107,186 | 110,438 | 220,766 | 222,397 | ||||||||||||
| Amortization of purchased intangible assets and other |
14,016 | 16,180 | 28,115 | 27,848 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| 764,578 | 773,006 | 1,529,344 | 1,516,361 | |||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Operating income |
138,000 | 123,848 | 279,521 | 244,538 | ||||||||||||
| Interest and other expense, net |
1,669 | 1,908 | 125 | 3,312 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Income before income taxes |
136,331 | 121,940 | 279,396 | 241,226 | ||||||||||||
| Income taxes |
20,070 | 11,583 | 32,145 | 29,434 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net income |
$ | 116,261 | $ | 110,357 | $ | 247,251 | $ | 211,792 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Basic earnings per share |
$ | 0.75 | $ | 0.69 | $ | 1.59 | $ | 1.33 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Diluted earnings per share |
$ | 0.74 | $ | 0.68 | $ | 1.57 | $ | 1.31 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Basic weighted average number of shares outstanding |
155,106 | 159,812 | 155,506 | 159,734 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Diluted weighted average number of shares outstanding |
157,357 | 162,251 | 157,738 | 162,048 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Cash dividends declared per share |
$ | 0.170 | $ | 0.155 | $ | 0.325 | $ | 0.285 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
AMDOCS LIMITED
Selected Financial Metrics
(in thousands, except per share data)
| Three months ended | Six months ended | |||||||||||||||
| March 31, | March 31, | |||||||||||||||
| 2015 | 2014 | 2015 | 2014 | |||||||||||||
| Revenue |
$ | 902,578 | $ | 896,854 | $ | 1,808,865 | $ | 1,760,899 | ||||||||
| Non-GAAP operating income |
153,491 | 150,563 | 306,453 | 295,886 | ||||||||||||
| Non-GAAP net income |
128,647 | 131,850 | 268,132 | 254,414 | ||||||||||||
| Non-GAAP diluted earnings per share |
$ | 0.82 | $ | 0.81 | $ | 1.70 | $ | 1.57 | ||||||||
| Diluted weighted average number of shares outstanding |
157,357 | 162,251 | 157,738 | 162,048 | ||||||||||||
AMDOCS LIMITED
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
(in thousands)
| Three months ended March 31, 2015 | ||||||||||||||||||||||||
| Reconciliation items | ||||||||||||||||||||||||
| GAAP | Amortization of purchased intangible assets and other |
Equity based compensation expense |
Changes in fair value of certain acquisition- related liabilities |
Tax effect | Non-GAAP | |||||||||||||||||||
| Operating expenses: |
||||||||||||||||||||||||
| Cost of revenue |
$ | 580,571 | $ | — | $ | (3,737 | ) | $ | 8,350 | $ | — | $ | 585,184 | |||||||||||
| Research and development |
62,805 | — | (817 | ) | — | — | 61,988 | |||||||||||||||||
| Selling, general and administrative |
107,186 | — | (5,271 | ) | — | — | 101,915 | |||||||||||||||||
| Amortization of purchased intangible assets and other |
14,016 | (14,016 | ) | — | — | — | — | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total operating expenses |
764,578 | (14,016 | ) | (9,825 | ) | 8,350 | — | 749,087 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Operating income |
138,000 | 14,016 | 9,825 | (8,350 | ) | — | 153,491 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Interest and other expense, net |
1,669 | — | — | — | — | 1,669 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Income taxes |
20,070 | — | — | — | 3,105 | 23,175 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Net income |
$ | 116,261 | $ | 14,016 | $ | 9,825 | $ | (8,350 | ) | $ | (3,105 | ) | $ | 128,647 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Three months ended March 31, 2014 | ||||||||||||||||||||
| Reconciliation items | ||||||||||||||||||||
| GAAP | Amortization of purchased intangible assets and other |
Equity based compensation expense |
Tax effect | Non-GAAP | ||||||||||||||||
| Operating expenses: |
||||||||||||||||||||
| Cost of revenue |
$ | 583,284 | $ | — | $ | (4,369 | ) | $ | — | $ | 578,915 | |||||||||
| Research and development |
63,104 | — | (872 | ) | — | 62,232 | ||||||||||||||
| Selling, general and administrative |
110,438 | — | (5,294 | ) | — | 105,144 | ||||||||||||||
| Amortization of purchased intangible assets and other |
16,180 | (16,180 | ) | — | — | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Total operating expenses |
773,006 | (16,180 | ) | (10,535 | ) | — | 746,291 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Operating income |
123,848 | 16,180 | 10,535 | — | 150,563 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Income taxes |
11,583 | — | — | 5,222 | 16,805 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Net income |
$ | 110,357 | $ | 16,180 | $ | 10,535 | $ | (5,222 | ) | $ | 131,850 | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
AMDOCS LIMITED
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
(in thousands)
| Six months ended March 31, 2015 |
||||||||||||||||||||||||
| Reconciliation items | ||||||||||||||||||||||||
| GAAP | Amortization of purchased intangible assets and other |
Equity based compensation expense |
Changes in fair value of certain acquisition- related liabilities |
Tax effect | Non-GAAP | |||||||||||||||||||
| Operating expenses: |
||||||||||||||||||||||||
| Cost of revenue |
$ | 1,154,017 | $ | — | $ | (7,981 | ) | $ | 24,906 | $ | — | $ | 1,170,942 | |||||||||||
| Research and development |
126,446 | — | (1,754 | ) | — | — | 124,692 | |||||||||||||||||
| Selling, general and administrative |
220,766 | — | (13,988 | ) | — | — | 206,778 | |||||||||||||||||
| Amortization of purchased intangible assets and other |
28,115 | (28,115 | ) | — | — | — | — | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total operating expenses |
1,529,344 | (28,115 | ) | (23,723 | ) | 24,906 | — | 1,502,412 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Operating income |
279,521 | 28,115 | 23,723 | (24,906 | ) | — | 306,453 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Interest and other expense, net |
125 | — | — | 3,921 | — | 4,046 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Income taxes |
32,145 | — | — | — | 2,130 | 34,275 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Net income |
$ | 247,251 | $ | 28,115 | $ | 23,723 | $ | (28,827 | ) | $ | (2,130 | ) | $ | 268,132 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Six months ended March 31, 2014 |
||||||||||||||||||||
| Reconciliation items | ||||||||||||||||||||
| GAAP | Amortization of purchased intangible assets and other |
Equity based compensation expense |
Tax effect | Non-GAAP | ||||||||||||||||
| Operating expenses: |
||||||||||||||||||||
| Cost of revenue |
$ | 1,140,687 | $ | — | $ | (8,923 | ) | $ | — | $ | 1,131,764 | |||||||||
| Research and development |
125,429 | — | (1,805 | ) | — | 123,624 | ||||||||||||||
| Selling, general and administrative |
222,397 | — | (12,772 | ) | — | 209,625 | ||||||||||||||
| Amortization of purchased intangible assets and other |
27,848 | (27,848 | ) | — | — | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Total operating expenses |
1,516,361 | (27,848 | ) | (23,500 | ) | — | 1,465,013 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Operating income |
244,538 | 27,848 | 23,500 | — | 295,886 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Income taxes |
29,434 | — | — | 8,726 | 38,160 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Net income |
$ | 211,792 | $ | 27,848 | $ | 23,500 | $ | (8,726 | ) | $ | 254,414 | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
AMDOCS LIMITED
Condensed Consolidated Balance Sheets
(in thousands)
| As of | ||||||||
| March 31, 2015 |
September 30, 2014 |
|||||||
| ASSETS |
||||||||
| Current assets |
||||||||
| Cash, cash equivalents and short-term interest-bearing investments |
$ | 1,292,489 | $ | 1,424,465 | ||||
| Accounts receivable, net, including unbilled of $103,752 and $134,523, respectively |
732,803 | 715,837 | ||||||
| Deferred income taxes and taxes receivable |
165,031 | 148,346 | ||||||
| Prepaid expenses and other current assets |
134,865 | 135,326 | ||||||
|
|
|
|
|
|||||
| Total current assets |
2,325,188 | 2,423,974 | ||||||
| Equipment and leasehold improvements, net |
285,402 | 288,956 | ||||||
| Goodwill and other intangible assets, net |
2,085,788 | 2,106,452 | ||||||
| Other noncurrent assets |
347,517 | 365,895 | ||||||
|
|
|
|
|
|||||
| Total assets |
$ | 5,043,895 | $ | 5,185,277 | ||||
|
|
|
|
|
|||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY |
||||||||
| Current liabilities |
||||||||
| Accounts payable, accruals and other |
$ | 800,848 | $ | 785,548 | ||||
| Short-term financing arrangements |
— | 210,000 | ||||||
| Deferred revenue |
185,234 | 156,743 | ||||||
| Deferred income taxes and taxes payable |
63,633 | 48,456 | ||||||
|
|
|
|
|
|||||
| Total current liabilities |
1,049,715 | 1,200,747 | ||||||
| Other noncurrent liabilities |
540,856 | 588,694 | ||||||
| Shareholders’ equity |
3,453,324 | 3,395,836 | ||||||
|
|
|
|
|
|||||
| Total liabilities and shareholders’ equity |
$ | 5,043,895 | $ | 5,185,277 | ||||
|
|
|
|
|
|||||
AMDOCS LIMITED
Consolidated Statements of Cash Flows
(in thousands)
| Six months ended March 31, | ||||||||
| 2015 | 2014 | |||||||
| Cash Flow from Operating Activities: |
||||||||
| Net income |
$ | 247,251 | $ | 211,792 | ||||
| Reconciliation of net income to net cash provided by operating activities: |
||||||||
| Depreciation and amortization |
83,303 | 76,739 | ||||||
| Equity-based compensation expense |
23,723 | 23,500 | ||||||
| Deferred income taxes |
(27,260 | ) | 9,690 | |||||
| Excess tax benefit from equity-based compensation |
(3,628 | ) | (438 | ) | ||||
| Loss from short-term interest-bearing investments |
283 | 679 | ||||||
| Net changes in operating assets and liabilities, net of amounts acquired: |
||||||||
| Accounts receivable |
(14,623 | ) | (30,503 | ) | ||||
| Prepaid expenses and other current assets |
3,522 | (6,424 | ) | |||||
| Other noncurrent assets |
14,898 | (14,867 | ) | |||||
| Accounts payable, accrued expenses and accrued personnel |
8,428 | 36,041 | ||||||
| Deferred revenue |
18,762 | 17,529 | ||||||
| Income taxes payable |
18,363 | (16,273 | ) | |||||
| Other noncurrent liabilities |
(29,388 | ) | 10,088 | |||||
|
|
|
|
|
|||||
| Net cash provided by operating activities |
343,634 | 317,553 | ||||||
|
|
|
|
|
|||||
| Cash Flow from Investing Activities: |
||||||||
| Payments for purchase of equipment and leasehold improvements, net |
(59,334 | ) | (51,971 | ) | ||||
| Proceeds from sale of short-term interest-bearing investments |
123,073 | 178,462 | ||||||
| Purchase of short-term interest-bearing investments |
(121,585 | ) | (189,691 | ) | ||||
| Net cash paid for acquisitions |
(8,099 | ) | (173,643 | ) | ||||
| Other |
509 | 3,151 | ||||||
|
|
|
|
|
|||||
| Net cash used in investing activities |
(65,436 | ) | (233,692 | ) | ||||
|
|
|
|
|
|||||
| Cash Flow from Financing Activities: |
||||||||
| Payments under financing arrangements |
(210,000 | ) | (200,000 | ) | ||||
| Repurchase of shares |
(212,195 | ) | (168,933 | ) | ||||
| Proceeds from employee stock options exercised |
58,116 | 98,327 | ||||||
| Payments of dividends |
(48,377 | ) | (41,564 | ) | ||||
| Excess tax benefit from equity-based compensation |
3,628 | 438 | ||||||
| Other |
(5 | ) | (281 | ) | ||||
|
|
|
|
|
|||||
| Net cash used in financing activities |
(408,833 | ) | (312,013 | ) | ||||
|
|
|
|
|
|||||
| Net decrease in cash and cash equivalents |
(130,635 | ) | (228,152 | ) | ||||
| Cash and cash equivalents at beginning of period |
1,103,269 | 1,014,192 | ||||||
|
|
|
|
|
|||||
| Cash and cash equivalents at end of period |
$ | 972,634 | $ | 786,040 | ||||
|
|
|
|
|
|||||
AMDOCS LIMITED
Supplementary Information
(in millions)
| Three months ended | ||||||||||||||||||||
| March 31, 2015 |
December 31, 2014 |
September 30, 2014 |
June 30, 2014 |
March 31, 2014 |
||||||||||||||||
| North America |
$ | 646.7 | $ | 659.1 | $ | 662.7 | $ | 647.2 | $ | 651.7 | ||||||||||
| Europe |
97.6 | 106.9 | 105.3 | 114.6 | 113.8 | |||||||||||||||
| Rest of the World |
158.3 | 140.3 | 132.3 | 140.7 | 131.4 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Total Revenue |
$ | 902.6 | $ | 906.3 | $ | 900.3 | $ | 902.5 | $ | 896.9 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| As of | ||||||||||||||||||||
| March 31, 2015 |
December 31, 2014 |
September 30, 2014 |
June 30, 2014 |
March 31, 2014 |
||||||||||||||||
| Managed Services Revenue |
$ | 448.8 | $ | 467.1 | $ | 436.4 | $ | 438.0 | $ | 426.3 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Three months ended | ||||||||||||||||||||
| March 31, 2015 |
December 31, 2014 |
September 30, 2014 |
June 30, 2014 |
March 31, 2014 |
||||||||||||||||
| Customer Experience Systems |
$ | 877.1 | $ | 882.4 | $ | 871.5 | $ | 870.8 | $ | 863.6 | ||||||||||
| Directory |
25.5 | 23.9 | 28.8 | 31.7 | 33.3 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| Total Revenue |
$ | 902.6 | $ | 906.3 | $ | 900.3 | $ | 902.5 | $ | 896.9 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
| As of | ||||||||||||||||||||
| March 31, 2015 |
December 31, 2014 |
September 30, 2014 |
June 30, 2014 |
March 31, 2014 |
||||||||||||||||
| 12-Month Backlog |
$ | 3,000 | $ | 3,030 | $ | 3,000 | $ | 2,970 | $ | 2,940 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
# # #